Corrigendum to \"Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial\" [The Breast 83 (2025) 104547].
AuteursDemeestere I, Niman SM, Partridge AH, Diego DS, Kammler R, Ruggeri M, Colleoni M, Shimizu C, Saura C, Gelmon KA, Saetersdal AB, Kroep JR, Mailliez A, Amant F, Ruız-Borrego M, Lee JE, Kataoka A, Walshe JM, Takei J, Borstnar S, Borges VF, Saunders C, Susnjar S, Bjelic-Radisic V, Cardoso F, Meisel JL, Kawwass JF, Spanic T, El-Abed S, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, Azim HA, Peccatori FA
Ustekinumab in Ulcerative Colitis: A Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN).
AuteursHolvoet T, Truyens M, Reenaers C, Baert F, Vanden Branden S, Cremer A, Pouillon L, Dewint P, Van Moerkercke W, Rahier JF, Vandermeulen L, Van Dongen J, Peeters H, Lambrecht G, Vijverman A, Van Haecke A, Hoorens A, Lobaton T
AuteursPansieri J, Menassa D, Figiel S, Pisa M, Lockhart A, Ricigliano VAG, Seferoglu M, Borrelli S, Pimentel V, Alpin N, Szejko N, Samadzadeh S, Boldrini V, Zarco L, Correa-Díaz EP, Dos Santos Silva J, Gomez Figueroa E, Carnero Contentti E, Koc ER, Dalla Costa G, Casallas-Vanegas A, Bakirtzis C, Gluscevic S, Carvajal R, Tunç A, Haider L
Factors associated with Early Neurological Deterioration in Minor Distal Medium Vessel Acute Ischemic Stroke: A Multinational Multicenter Study.
AuteursLakhani DA, Salim HA, Yedavalli V, Musmar B, Milhem F, Adeeb N, Faizy TD, Daraghma M, El Naamani K, Henninger N, Sundararajan SH, Kuhn A, Khalife J, Ghozy S, Scarcia L, Yeo L, Tan BY, Regenhardt R, Heit J, Cancelliere NM, Rouchaud A, Fiehler J, Sheth SA, Puri AS, Dyzmann C, Colasurdo M, Renieri L, Filipe JP, Harker P, Radu RA, Abdalkader M, Klein P, Marrota T, Spears J, Ota T, Mowla A, Jabbour P, Biswas A, Clarencon F, Siegler JE, Nguyen TN, Varela R, Baker A, Essibayi MA, Altschul D, Gonzalez N, Möhlenbruch M, Costalat V, Gory B, Stracke C, Hecker C, Marnat G, Shaikh H, Griessenaur C, Liebeskind DS, Pedicelli A, Alexandre A, Tancredi I, Kalsoum E, Lubicz B, Patel AB, Pereira VM, Wintermark M, Guenego A, Dmytriw A
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
AuteursMathieu C, Wych J, Hendriks AEJ, Van Ryckeghem L, Tree T, Chmura P, Möller C, Casteels K, Danne T, Reschke F, Šmigoc Schweiger D, Battelino T, Johannesen J, Rami-Merhar B, Pieber T, De Block C, Evans M, Hilbrands R, Bosi E, Willemsen RH, Basu S, Pulkkinen MA, Knip M, Cnop M, Nitsche A, Schulte AM, Niemöller E, Peakman M, Wilhelm-Benartzi C, Gillespie D, Overbergh L, Mander AP, Marcovecchio ML
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.
AuteursVan Vooren E, Van Den Broeck F, Mahieu Q, Geens E, Van Heetvelde M, De Bruyne M, Van de Sompele S, Uppal S, Poliakov E, Dhaenens CM, Gregory-Evans CY, Hoefsloot L, Gonzalez AI, Kohl S, Zuleger T, Demaret T, Tuupanen S, Ruys J, Van Os L, Platteau E, Jacob J, Vermeer S, Postelmans L, Dahan K, Maystadt I, Rasquin F, Thiadens AAHJ, Stephenson KAJ, Sheri N, Smirnov V, MacDonald IM, Gregory-Evans K, Redmond TM, De Zaeytijd J, Leroy BP, Bauwens M, De Baere E
